Exemestane Completed Phase N/A Trials for Stage IV Breast Cancer / Stage IIIC Breast Cancer / Estrogen Receptor-Positive Breast Cancer / Progesterone Receptor Positive Tumor / Recurrent Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01385280Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer